BPI25-017: A Novel Integrated Classification Schema for Molecular Findings by Potential Clinical Actionability: A Tool for Assessment of Real-World Cancer Care in the Targeted Therapy Era
"BPI25-017: A Novel Integrated Classification Schema for Molecular Findings by Potential Clinical Actionability: A Tool for Assessment of Real-World Cancer Care in the Targeted Therapy Era" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- John Rothen
- Carolyn Jean Presley (ORCID: https://orcid.org/0000-0002-2607-5639)
- Sarah B. Goldberg (ORCID: https://orcid.org/0000-0002-0920-1381)
- Ronac Mamtani (ORCID: https://orcid.org/0000-0002-8267-5356)
- Natalia Kunst (ORCID: https://orcid.org/0000-0002-2409-4246)
- Shuangge Ma (ORCID: https://orcid.org/0000-0001-9001-4999)
- Cary P. Gross (ORCID: https://orcid.org/0000-0002-4974-935X)
- Timothy J. Robinson (ORCID: https://orcid.org/0000-0003-0021-0668)
- Michaela A. Dinan (ORCID: https://orcid.org/0000-0003-4849-4743)
- Xiao Wang (ORCID: https://orcid.org/0000-0003-3238-5366)
- Shi‐Yi Wang (ORCID: https://orcid.org/0000-0002-3294-5784)
- Pamela R. Soulos
- Sida Huang
- Jessica B. Long
Institutions
- Yale Cancer Center (US)
- Yale University (US)
- University of York (GB)
- The Ohio State University (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7205
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00